Home / Anti-infectives / Ampicillin
ATC J01CA01 · Penicillins with Extended Spectrum
Ampicillin shortage
As of 2 Nov 2026, Ampicillin has a reported shortage in 2 of the 15 countries we track (United States, Canada), covering 10 products from 3 companies.
Countries2/15
Products10packs or presentations
Companies32 listed
Short since10 Mar 20179.6 years ago
Earliest returnnot givencompany estimate
Main reasonNot stated
United States5 products shortCanada5 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Timeline
United StatesCanada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group J01CA · Penicillins with Extended SpectrumAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Ampicillin Sodium, Injection, 1 g (NDC 0781-9404-95) discontinuation | Sandoz Inc. | 8 Dec 2025 | not given | Not stated |
| US | Ampicillin Sodium, Injection, 1 g (NDC 0781-9412-92) discontinuation | Sandoz Inc. | 8 Dec 2025 | not given | Not stated |
| US | Ampicillin Sodium, Injection, 10 g (NDC 0781-9409-95) discontinuation | Sandoz Inc. | 8 Dec 2025 | not given | Not stated |
| US | Ampicillin Sodium, Injection, 2 g (NDC 0781-9408-95) discontinuation | Sandoz Inc. | 8 Dec 2025 | not given | Not stated |
| US | Ampicillin Sodium, Injection, 2 g (NDC 0781-9413-92) discontinuation | Sandoz Inc. | 8 Dec 2025 | not given | Not stated |
| CA | APO AMPI CAPSULES 250MG (100 BTL & 1000 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO AMPI CAPSULES 500MG (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO AMPI LIQ 125MG/5ML (60/100/150 ML) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO AMPI LIQ 250MG/5ML (60/100/150 ML) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-AMPICILLIN (100) | TEVA CANADA LIMITED | 11 Feb 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.